| Financial Year |
March 31 2023 |
| Monetary Funds |
914,007,222.79 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
488,042,870.83 |
| Advances to Suppliers |
168,944,483.49 |
| Other Receivables |
56,255,103.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
424,772,631.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,124,670.49 |
| Total Current Assets |
2,072,599,945.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
64,165,625.61 |
| Investment Properties |
-- |
| Fixed Assetes |
712,554,371.03 |
| Under-construction Projects |
64,647,283.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
109,571,577.51 |
| R&D expenses |
-- |
| Goodwill |
9,585,684.07 |
| Long-Term Deferred and Prepaid Expenses |
22,656,732.40 |
| Deferred Income Tax Assets |
12,139,409.43 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,097,498,639.75 |
| Total Assets |
3,170,098,585.62 |
| Short-Term Loans |
272,142,620.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
83,518,907.48 |
| Accounts Payable |
357,870,552.74 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
37,665,918.69 |
| Taxes Payable |
56,292,333.22 |
| Interest Payable |
202,943.93 |
| Dividend Payable |
-- |
| Other payables |
30,958,435.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
23,265,459.55 |
| Other Current Liabilities |
965,853.39 |
| Sub-Total of Current Liabilities |
875,850,641.94 |
| Long-term Loans |
87,713,893.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,264,796.56 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
182,317,266.59 |
| Total Liabilities |
1,058,167,908.53 |
| Paid-In Capital(Or Share Stock) |
378,409,288.00 |
| Capital Surplus |
161,378,912.95 |
| Surplus Reserve |
69,894,898.63 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,475,924,036.13 |
| Minority Stockholder's Interest |
38,747,578.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,073,183,098.98 |
| Owner's Equity（Stockholder's Equity） |
2,111,930,677.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,170,098,585.62 |
